Literature DB >> 19509102

Genetic variants of TCF7L2 are associated with insulin resistance and related metabolic phenotypes in Taiwanese adolescents and Caucasian young adults.

Pi-Hua Liu1, Yi-Cheng Chang, Yi-Der Jiang, Wei J Chen, Tien-Jyun Chang, Shan-Shan Kuo, Kuan-Ching Lee, Po-Chang Hsiao, Ken C Chiu, Lee-Ming Chuang.   

Abstract

OBJECTIVES: The effect of TCF7L2 rs7903146 on glucose homeostasis is considered primarily due to impaired insulin secretion in European populations. Because we previously demonstrated that TCF7L2 rs290487 near the 3' end of TCF7L2 was significantly associated with type 2 diabetes (T2D) in Taiwanese subjects, we aimed to investigate potential mechanisms underlying the associations of rs290487 with T2D.
METHODS: Eighteen single nucleotide polymorphisms (SNPs) were tested for association with glucose/insulin homeostasis as well as other quantitative metabolic phenotypes using the quantitative transmission disequilibrium test in 525 Taiwanese adolescent twin-pairs and siblings. The results were further replicated in 116 nondiabetic normotensive Caucasian young adults.
RESULTS: Among the 18 SNPs, rs290487 C allele was significantly associated with higher 60-, 90-, and 120-min glucose concentrations (P = 0.001, 0.01, and 0.02, respectively); higher 60- and 90-min insulin concentrations (P = 0.01 and 0.01, respectively); and a lower insulin sensitivity index (P = 0.04). No association was found for rs290487 with measures of insulin secretion. The rs290487 C allele was also associated with HOMA-IR (P = 0.005) and insulin sensitivity index (P = 0.01) in Caucasian young adults. Another SNP, rs10749127 C allele located in intron 4, was also associated with features of the metabolic syndrome, including elevated systolic (P = 0.02) and diastolic (P = 2.0 x 10(-4)) blood pressure, triglycerides (P = 7.0 x 10(-4)), and uric acid (P = 0.03). In a meta-analysis, the rs290487 C allele was confirmed to be associated with an increased risk of T2D (odds ratio, 1.11; 95% confidence interval, 1.03-1.19; P = 0.005) across East Asian populations.
CONCLUSIONS: These findings support an important role for T2D risk-conferring gene TCF7L2 in insulin resistance in both Taiwanese and Caucasian youth and underscore the emerging role of Wnt signaling in insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19509102     DOI: 10.1210/jc.2009-0609

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

Review 1.  Harnessing low-density lipoprotein receptor protein 6 (LRP6) genetic variation and Wnt signaling for innovative diagnostics in complex diseases.

Authors:  Z-M Wang; J-Q Luo; L-Y Xu; H-H Zhou; W Zhang
Journal:  Pharmacogenomics J       Date:  2017-07-11       Impact factor: 3.550

2.  Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes.

Authors:  Axel Haupt; Claus Thamer; Martin Heni; Caroline Ketterer; Jürgen Machann; Fritz Schick; Fausto Machicao; Norbert Stefan; Claus D Claussen; Hans-Ulrich Häring; Andreas Fritsche; Harald Staiger
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

3.  LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans.

Authors:  Rajvir Singh; Renata Belfort De Aguiar; Sarita Naik; Sheida Mani; Kamal Ostadsharif; Detlef Wencker; Masoud Sotoudeh; Reza Malekzadeh; Robert S Sherwin; Arya Mani
Journal:  Cell Metab       Date:  2013-02-05       Impact factor: 27.287

4.  TCF7L2 Genotype and α-Cell Function in Humans Without Diabetes.

Authors:  Meera Shah; Ron T Varghese; John M Miles; Francesca Piccinini; Chiara Dalla Man; Claudio Cobelli; Kent R Bailey; Robert A Rizza; Adrian Vella
Journal:  Diabetes       Date:  2015-11-02       Impact factor: 9.461

5.  TCF7L2 genetic variants and progression to diabetes in the Chinese population: pleiotropic effects on insulin secretion and insulin resistance.

Authors:  Yi-Cheng Chang; Yen-Feng Chiu; Larry Low-Tone Ho; Chih-Tai Ting; Kuang-Chung Shih; J David Curb; Yii-Der Ida Chen; Hung-Yuan Li; Lee-Ming Chuang
Journal:  J Mol Med (Berl)       Date:  2009-10-06       Impact factor: 4.599

6.  Diabetes-Associated Variation in TCF7L2 Is Not Associated With Hepatic or Extrahepatic Insulin Resistance.

Authors:  Ron T Varghese; Ivan Viegas; Cristina Barosa; Catia Marques; Meera Shah; Robert A Rizza; John G Jones; Adrian Vella
Journal:  Diabetes       Date:  2016-01-28       Impact factor: 9.461

Review 7.  The Role of TCF7L2 in Type 2 Diabetes.

Authors:  Laura Del Bosque-Plata; Eduardo Martínez-Martínez; Miguel Ángel Espinoza-Camacho; Claudia Gragnoli
Journal:  Diabetes       Date:  2021-05-20       Impact factor: 9.461

8.  Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1.

Authors:  Galina Smushkin; Matheni Sathananthan; Airani Sathananthan; Chiara Dalla Man; Francesco Micheletto; Alan R Zinsmeister; Claudio Cobelli; Adrian Vella
Journal:  Diabetes       Date:  2012-03-28       Impact factor: 9.461

9.  Association of fibrillin-3 and transcription factor-7-like 2 gene variants with metabolic phenotypes in PCOS.

Authors:  Sudha K Yalamanchi; Susan Sam; Maria O Cardenas; Louisa W Holaday; Margrit Urbanek; Andrea Dunaif
Journal:  Obesity (Silver Spring)       Date:  2012-02-02       Impact factor: 5.002

10.  Association of rs7903146 (IVS3C/T) and rs290487 (IVS3C/T) polymorphisms in TCF7L2 with type 2 diabetes in 9,619 Han Chinese population.

Authors:  Jinjin Wang; Linlin Li; Jiatong Zhang; Jing Xie; Xinping Luo; Dahai Yu; Jingzhi Zhao; Tianping Feng; Chao Pang; Lei Yin; Fulan Hu; Jianfeng Zhang; Yan Wang; Qian Wang; Yujia Zhai; Haifei You; Tian Zhu; Dongsheng Hu
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.